Neo-adjuvant Temsirolimus in Patients With Advanced Renal Cell Carcinoma

Summary

Temsirolimus is a drug that is being studied to possibly treat kidney cancer. It works by starving the cancer of nutrients, by cutting off the blood supply, which is hoping to shrink the cancer. This study will look at the experimental use of temsirolimus, 12 weeks prior to the surgical removal of the entire kidney or a portion of the kidney that is involved by the tumor.

Timeline

Start

2008-09

Primary completion

2014-08

Completion

2014-08

Drugs

Indications